Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA9 | Q16790 | 4/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.43 |
| ▸ | EDNRB | P24530 | 1/20 | 0.40 |
| ▸ | EDNRA | P25101 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.40 |
| ▸ | TNF | P01375 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24307854 | 0.97 | CA12 (0.49) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24307303 | 0.97 | CA12 (0.49) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24307863 | 0.96 | CA12 (0.46) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24307846 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24306672 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24862061 | 0.95 | CA12 (0.47) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24307852 | 0.95 | CA12 (0.47) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24862184 | 0.95 | CA12 (0.47) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24307833 | 0.95 | CA12 (0.47) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL29610791 | 0.95 | CA12 (0.47) | CA12CA1CA2CA9MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4195304-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2023-06-14 | — | — | EP | disclosed |
| EP-4116393-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2023-01-11 | — | — | EP | disclosed |
| US-20210210693-A1 | COMPOUND HAVING TRIARYLAMINE STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2021-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210210693-A1 | COMPOUND HAVING TRIARYLAMINE STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | SLC7A5, LEF1, SLC43A1 | CA12 4264/4885CA1 4479/4885CA2 4380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.